BlackRock »

Plus Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $420k 96k 4.37

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding Plus Therapeutics

Vanguard Capital Management
BlackRock
Geode Capital Management
Vanguard Fiduciary Trust
Ashton Thomas Private Wealth
Citadel Advisors
Northern Trust
Virtu Financial
Hrt Financial
Wells Fargo & Company
Vanguard Global Advisers
Advisor Group Holdings
Tower Research Capital
Allied Private Wealth
UBS Group

View all funds holding Plus Therapeutics